Immunocore · 7 hours ago
Oncology Account Manager - Northern California
Immunocore is a pioneering biotechnology company focused on developing transformative medicines for oncology and other diseases. The Oncology Account Manager will be responsible for driving sales performance and building key relationships with healthcare professionals and stakeholders within the assigned territory.
BiotechnologyHealth CareMedicalPharmaceutical
Responsibilities
Drive sales results by identifying key opportunities and developing strategic business plans to generate product utilization and grow territory business
Demonstrate deep marketplace, therapeutic, product and disease expertise and educate customers on company products consistent with all requirements for the promotion of drug products
Build and maintain strong professional relationships with target physicians, non-physician healthcare professionals (HCPs), office and hospital staff, and others in the patient care continuum, as directed
Proactively address customer needs, identify market dynamics and trends, develop local tactics that support brand and corporate objectives/strategies and ensure optimal success within their assigned territory
Analyze data/information to create, implement territory business action plans (using approved sales tools) that enhance customer relationships and drive sales results
Strategically identify and build relationships with appropriate new targets based on referral patterns and patient migration
Thoroughly understand account-level decisions that impact product access within territory and develop plans on to best address to ensure patient access to care (such as product placement on formulary and inclusion into Electronic Medical Records (EMRs))
Appropriately communicate and collaborate with field partners on issues impacting both territory and national markets that support brand
Demonstrate market knowledge and leadership with both internal stakeholders (including cross functional teams such as Market Access, Field Reimbursement, Operations, Marketing, Trade and Sales teams) and external stakeholders (Centers of Excellence (COE) decision makers, Key Opinion Leaders (KOLs), etc.)
Plan, organize, and execute local promotional speaker programs and activities, consistent with company policies
Maximize budget allocated to the geographic territory to support execution of strategies and tactics and generate/grow the business
Understand concepts of coding, billing and reimbursement for HCP-administered product
Operate in full compliance with company policies, local codes of conduct and ethics, corporate governance and applicable law
Implement business in accordance with the highest ethical, legal, and compliance standards, including timely and successful completion of all required training
Qualification
Required
7+ years of demonstrated experience and proven sales success in biotech / pharmaceutical industry
5+ years demonstrated account/territory management experience
Relevant Oncology or Rare Disease/Orphan Drug experience with HCP-administered product(s) preferred
Successful experience in product launches and execution of launch strategies/tactical plans
Demonstrated ability to learn and apply technical and scientific product-related information
Proven success and positive track record of consistent sales performance in complex markets with diverse customer segments operating with a high degree of integrity within compliance guidelines
Bachelor's degree – BA/BS required
Field-based role with at least 75% travel to engage with customers face-to-face
Candidates must live in close proximity to a major airport
Valid driver's license
Must be able fly/drive to cover assigned geography
Additional travel to meetings/trainings/programs, as necessary
Preferred
Relevant Oncology or Rare Disease/Orphan Drug experience with HCP-administered product(s) preferred
Benefits
Medical
Dental
Vision
Time off
401k
Participating in Immunocore's annual incentive plans
Company
Immunocore
Immunocore is a biotechnology company that specializes in the development of TCR bispecific immunotherapies.
Funding
Current Stage
Public CompanyTotal Funding
$1.16BKey Investors
BlackRockOxford Finance LLCGeneral Atlantic
2024-01-30Post Ipo Debt· $350M
2022-07-18Post Ipo Equity· $140M
2021-02-04IPO
Recent News
2026-02-02
2025-11-29
Company data provided by crunchbase